The M&A trend isn’t showing any signs of slowing.
Opportunities to lower drug prices, as promised by President Trump’s American Patients First Blueprint, are picking up steam, some progressing more quickly than others.
What are some of the implications of executive order on transparency in healthcare?
Here’s what it’s going to take to succeed.
The highest expense for many U.S. households makes this top of mind for employees.
Where claims are coming from—and how to stop them.
Guidelines from the real-world experiences of ACO leaders.
How MCOs are delivering value to Medicaid populations.
New study shows that billions may be wasted on unnecessary ED visits.
How the president’s Advancing American Kidney Health’ Initiative will impact policy.